CLINICAL_TRIALS
trial_result
· 2015-04-24
Clinical Trial Update: Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula [Phase 3]
Summary
A Phase 3 trial evaluating the tolerance and efficacy of a new anti-regurgitation formula for gastroesophageal reflux disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Pharmaceuticals | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED